Magnetar Financial’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Magnetar Financial’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,639,599	Closed	-$67.9M	–	1995
2022 Q1	$67.9M	Buy	3,639,599 +1,864,265	+105%	+$33.5M	0.72%	26
2021 Q4	$38M	Buy	1,775,334 +1,437,666	+426%	+$28.3M	0.38%	48
2021 Q3	$6.24M	Buy	+337,668	New	+$6.8M	0.06%	302

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Magnetar Financial's OCDX Position: Q2 2022 in Review

Magnetar Financial sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 3,639,599 shares — an estimated $67.9M sold.

Magnetar Financial first reported a position in OCDX in Q3 2021 and held it in 3 quarters. The position peaked at $67.9M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Magnetar Financial reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Magnetar Financial sold 3,639,599 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $67.9M.
Magnetar Financial first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 3 quarters.
Magnetar Financial's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $67.9M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Magnetar Financial's 13F filing for Q2 2022, filed 15 Aug 2022.